Not a good year for Viscount and Implant Sciences. If they had "hit" like I was expecting them to, retirement would have been sooner rather than later.
I still have some hope for both of them, but I have less faith in Viscount than in Implant Sciences. Maybe the big issue to take away from both of them is that if you are a small company dealing with the government, timelines will almost always fall by the wayside. I am not sure who is to blame here. The companies or the government. My guess they both have some blame here.
With Implant Sciences, I was expecting at least 10 million in the quarter. Their guidance makes it seem that they will build to a 10 million dollar quarter. So they will keep hemorrhaging cash for at least the next couple of months, barring the TSA stepping up whatever timeline they are on. No wonder they are waiting on refinancing. It really isn't an option right now. I would guess someone will pick them up on the cheap if they can't build revenues significantly more than their guidance speaks to.
With Viscount, I think it was worth the effort of a new sales force but it doesn't seem that anyone can push their solution any faster than what is happening. I am selling this off a bit each month, hoping that somehow some value can be found and the share price will rebound but I am afraid that ship has sailed.
I think I am done with small companies for a while. I will be looking to diversify my portfolios more and look at a dividend strategy that will give me enough cash flow to retire. It has been a while since I hit a decent winner in the small cap space.
Good luck to you.